13535-47-2Relevant academic research and scientific papers
KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
-
, (2019/06/05)
The present invention is directed to kinase inhibitor compounds having the following structure: or a stereoisomer, pharmaceuticallyacceptable salt, oxide, or solvate thereof, where R1, R2, X, n, R3, Y, Z, R4, R
FUSED HETEROARYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION
-
Page/Page column 23, (2012/06/01)
This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables A, Q, J, R1, R3, and R5 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
